FindTrial
Sign In

Clinical manifestations and kinetics of neutralizing antibodies in different Novel Coronavirus infections

Clinical manifestations and kinetics of neutralizing antibodies in different Novel Coronavirus infections

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056002
Enrollment
Unknown
Registered
2022-01-30
Start date
2021-08-01
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus pneumonia

Interventions

delta group:
non-delta group:

Sponsors

The First Affiliated Hospital of Xiamen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. COVID-19 patients admitted to our hospital from the beginning of the epidemic to July 2021; 2. Aged 18-80 years.

Exclusion criteria

Exclusion criteria: 1. Basic diseases affecting hemodynamics; 2. Pregnant women.

Design outcomes

Primary

MeasureTime frame
Neutralizing antibody levels in different specimens;—

Countries

China

Contacts

Public ContactYao Xiangyang

The First Affiliated Hospital of Xiamen University

tobyyo2000@163.com+86 13860181358

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026